ArticleBMC public health2026
A community-based programme to reduce non-communicable disease risk among persons living in disadvantaged neighbourhoods in three European countries: protocol for a controlled trial.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundNon-communicable diseases (NCDs) are the leading cause of premature death in Europe and disproportionately affect persons experiencing disadvantages (i.e., low-income populations, migrants and ethnic minorities). The Health Outcomes from Raised Urban Settings (HORUS) evaluation study aims to implement and evaluate a community-based programme, based on the social-ecological model, to reduce key modifiable NCD risk factors. The study is performed in three European cities (Rijeka, Croatia; Rotterdam, The Netherlands, and Valencia, Spain).
methodsThe HORUS programme will be evaluated using a mixed-methods, controlled study design. A total of 900 participants will be recruited: 150 in the intervention group and 150 in the control group at each study site. Self-reported data will be collected at baseline (T0) and at 9-month follow-up (T1). The primary outcome measured is change in lifestyle across four domains: diet, physical activity, alcohol consumption and smoking. In addition, implementation outcomes will be assessed, including acceptability, appropriateness, feasibility, adoption, penetration, implementation costs, and sustainability. DISCUSSION: The HORUS study will generate robust evidence on the effectiveness and implementation of community-based interventions for NCD prevention targeting disadvantaged neighbourhoods. Findings will inform the development of scalable, equity-oriented strategies to promote healthier lifestyles and reduce NCD risk factors in neighbourhoods across Europe.
trial registrationISRCTN registry number is ISRCTN11383698. Date of registration is 4/8/2025. https://www.isrctn.com/ISRCTN11383698 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.